The tweet was deleted by the author.
But we saved everything 🙂.
Alignment Healthcare Chairman and CEO John Kao will appear today on @healthtechnerds to discuss Medicare Advantage and the company's next phase of growth.
The appearance is scheduled for 1 p.m. EDT, or 10 a.m. PDT. Details are being clarified.
ALHC is trading at $19.56, which is well above the MA-20 ($16.38), MA-50 ($18.62), and MA-200 ($18.61), showing the stock maintains a bullish underlying trend across short, medium, and long-term timeframes. The Ichimoku Kijun on D1 is at $17.15, which acts as immediate support just below the current price.
Momentum on D1 is moderately positive with ADX signaling buy and MACD indicating neutrality, but oscillators show overbought conditions as Stoch RSI and CCI are both elevated and BBP signals strong buyer dominance. RSI on D1 is in the bullish zone at 62.11. Over the past week, ALHC has slipped $0.19 (0.89%) from the previous weekly close of $19.75. The current price sits in the upper part of the weekly range, which spanned from $15.24 to $21.25, and weekly volatility stands at 39.44%. This performance reflects a mild pullback after testing higher levels, with price consolidating near resistance.
For the coming week, the anticipated price range for ALHC is $18.60 to $20.60, keeping current levels well between the 52-week low ($11.63) and high ($23.87). The implied probability of a price increase is very high (more than 80%) based on buy signals from MA-50-W1, RSI-W1, and strong medium-term moving average support, making a price decline less likely. Baseline scenario: the stock moves sideways within this forecast band. Bullish scenario: a breakout above $20.60 could signal further upside momentum. Bearish scenario: a drop below immediate support at $18.60 would open room for deeper consolidation.
Earlier, analysts noted that Alignment Healthcare faced continued downside pressure, with persistent bearish momentum weighing on the stock’s performance. This article expands upon that outlook by examining whether recent developments provide any sign of stabilization or if risks of further downside remain, highlighting the importance of monitoring for shifts in momentum as a signal for potential trend reversal.